PDE-4 Inhibition in Sarcoidosis Patients: A Retrospective Single-Center Analysis of 51 Patients

<b>Background</b>: Several sarcoidosis patients require treatment with corticosteroids to prevent organ damage and control symptoms. However, corticosteroids are associated with numerous side effects and can be detrimental to patients if used long-term. Roflumilast is approved for the treatment of c...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Martin Elias Feineis, Charlott Terschluse, Louis Jouanjan, Daniel Soriano, Prerana Agarwal, Jonas Schupp, Joachim Müller-Quernheim, Daiana Stolz, Björn Christian Frye
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-11-01
coleção:	Pharmaceuticals
Assuntos:	sarcoidosis roflumilast lung function PDE-IV inhibitors
Acesso em linha:	https://www.mdpi.com/1424-8247/18/11/1729
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!